Perspective - Hematology and Blood Disorders (2023) Volume 6, Issue 3
Exploring the Role of Oxidative Stress in Hemolytic Disorders
Department of hematology
- *Corresponding Author:
- Batailler Caton
Department of hematology
Claude Bernard Lyon 1 University
Received:28-Aug-2023,Manuscript No.AAHBD- 23-112146; Editor assigned:31-Aug-2023,PreQC No.AAHBD- 23-112146(PQ); Reviewed:14-Sept-2023,QC No. AAHBD- 23-103247; Revised:20-Sept-2023, Manuscript No.AAHBD- 23-112146(R); Published:27-Sept-2023,DOI:10.35841/ aahbd-6.3.155
Citation: Caton B. Exploring the Role of Oxidative Stress in Hemolytic Disorders. Hematol Blood Disord. 2023;6(3):155
Red Blood Cells (RBCs) are prematurely destroyed in a variety of illnesses known as hemolytic disorders, which can have serious clinical repercussions. The significance of oxidative stress in the histopathology of various illnesses has received increasing attention in recent years. Oxidative stress, which results from an imbalance between the formation of Reactive Oxygen Species (ROS) and the antioxidant defense mechanisms of the cell, has been identified as a key factor in RBC malfunction and consequent hemolysis. Red blood cells are especially vulnerable to oxidative damage because they lack a nucleus and have a high metabolic rate, which can affect their membrane integrity, deformability, and overall survival. The main topic of this review is the role of oxidative stress in various acquired and hereditary hemolytic diseases..
The pathophysiology of hereditary diseases such as sickle cell anemia, thalassemia, and Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is influenced by specific patterns of oxidative damage. Similar to this, acquired illnesses like autoimmune hemolytic anemia show how oxidative stress, immunological dysregulation, and RBC destruction interact in intricate ways. Red Blood Cells (RBCs) are prematurely destroyed in hemolytic diseases, which include a wide range of ailments with various underlying causes and clinical symptoms..
Due to the potential for both acute and long-term repercussions, these illnesses provide serious difficulties for both patients and clinicians. Emerging knowledge in recent years has shown the crucial function of oxidative stress in the pathogenesis of hemolytic diseases. Numerous disorders, including those affecting the hematological system, have been linked to the onset and advancement of oxidative stress, which results from an imbalance between the generation of Reactive Oxygen Species (ROS) and the cell's antioxidant defense mechanisms. Red blood cells are unusually susceptible to oxidative stress because of their dependence on oxygen metabolism and lack of a nucleus, even though they are well-equipped to carry out their vital oxygen transport job. Maintaining RBC integrity depends heavily on the delicate balance between cellular antioxidant defenses and ROS production..
When this equilibrium is upset, oxidative damage within the reticuloendothelial system can result in membrane fragility, altered cell shape, and increased vulnerability to phagocytosis. This process has been linked to the pathophysiology of a number of hemolytic disorders, including acquired diseases like autoimmune hemolytic anemia and genetic abnormalities including sickle cell disease, thalassemia, and Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. We intend to explore the intricate connection between oxidative stress and hemolytic diseases in this study..
We will go through the causes of ROS production in RBCs, the antioxidant defense mechanisms these cells deploy, and how oxidative stress affects the pathophysiology of different hemolytic diseases. This review aims to pave the way for the development of novel therapeutic options that may ultimately lessen the burden of hemolytic disorders for afflicted persons by illuminating the complex relationships between oxidative stress and disease progression. This in-depth analysis seeks to clarify the complex connection between oxidative stress and hemolytic diseases. An overview of the origins of ROS within RBCs, such as hemoglobin auto-oxidation, enzymatic processes, and external triggers, is given in the review's opening paragraph. The complex system of antioxidant defenses used by RBCs to mitigate oxidative stress is then investigated. This system includes both non-enzymatic compounds like glutathione and ascorbic acid as well as enzymatic antioxidants like superoxide dismutase and glutathione peroxidase. The main topic of this review is the role of oxidative stress in various acquired and hereditary hemolytic diseases. The pathophysiology of hereditary diseases such as sickle cell anemia, thalassemia, and Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is influenced by specific patterns of oxidative damage. Similar to this, acquired illnesses like autoimmune hemolytic anemia show how oxidative stress, immunological dysregulation, and RBC destruction interact in intricate ways..
The potential of oxidative stress as a target for therapeutic approaches in hemolytic diseases is highlighted by this review. New methods for reducing oxidative damage have been made possible by recent discoveries in research, including antioxidant supplements, control of ROS-producing enzymes, and investigation of anti-inflammatory drugs. This study seeks to help to the development of novel therapies that may lessen the clinical burden of these ailments by giving a thorough overview of the interaction between oxidative stress and hemolytic disorders. In conclusion, investigating oxidative stress in hemolytic illnesses is an important first step in figuring out the pathogenesis and development of diseases. Exciting options for therapeutic intervention are presented by the intricate interplay between oxidative stress and the pathways directing RBC function, which has the potential to enhance quality of life for those suffering from hemolytic diseases.
- Joly BS, Coppo P, Veyradier A.Thrombotic thrombocytopenic purpuraBlood,Am J Hematol. 2017;129(21):2836-46.
- Chaturvedi S, Oluwole O, Cataland S et al.Post-traumatic stress disorder and depression in survivors of thrombotic thrombocytopenic purpura Thromb Res. 2017;151:51-6.
- Creamer M, Bell R, Failla S.Psychometric properties of the impact of event scale—Revised. Behav Res Ther. 2003;41(12):1489-96.
- Azoulay É, Kentish-Barnes N, Pochard F.Health-related quality of life: An outcome variable in critical care survivorsChest. 2008;133(2):339-41.
- Perkins JD, Wilkins SS, Kamran S, et al.Post-traumatic stress disorder and its association with stroke and stroke risk factors: A literature review. Neurobiol Stress. 2021;14:100332.